Literature DB >> 2656345

Effects of low insulin levels on rat embryonic growth and development.

J P Travers1, M K Pratten, F Beck.   

Abstract

The risk of congenital abnormality in diabetic pregnancy is about four times that for the normal population. Past clinical studies have suggested hyperglycemia and hyperketonemia as the factors responsible for these abnormalities, with no reference to the possible effects of low insulin levels. We examine the effect of hypoinsulinemia on rat embryonic growth and development in culture while normal glucose levels are maintained. With anti-insulin antibody bound to an affinity column containing cyanogen bromide-activated Sepharose 4B beads, insulin was selectively removed from the homologous culture serum eluted down the column. A culture of rat embryos from the early head-fold stage for 50 h in insulin-depleted normoglycemic homologous serum (insulin levels 0.055-0.18 ng/ml) showed retardation of growth and development when compared with control embryos. Adding physiological amounts (10 ng/ml) of insulin back into the insulin-depleted serum subsequently restored growth level to that of control embryos. We conclude that low insulin levels, encountered in newly diagnosed diabetic pregnancy, may be instrumental in increasing the risk of congenital abnormalities.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2656345     DOI: 10.2337/diab.38.6.773

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  10 in total

1.  Proinsulin: much more than a hormone precursor in development.

Authors:  Catalina Hernández-Sánchez; Oscar Bártulos; Flora de Pablo
Journal:  Rev Endocr Metab Disord       Date:  2005-08       Impact factor: 6.514

2.  Experimental diabetes impairs rat embryo development during the preimplantation period.

Authors:  M Vercheval; R De Hertogh; S Pampfer; I Vanderheyden; B Michiels; P De Bernardi; R De Meyer
Journal:  Diabetologia       Date:  1990-04       Impact factor: 10.122

3.  Species-specificity of growth-promoting effects of prolactin during rat embryogenesis.

Authors:  A K Karabulut; M K Pratten
Journal:  J Anat       Date:  1998-01       Impact factor: 2.610

4.  The role of maternally derived epidermal growth factor and the epidermal growth factor receptor during organogenesis in the rat embryo.

Authors:  C A Tebbs; P F Cumberland; M K Pratten
Journal:  J Anat       Date:  1997-05       Impact factor: 2.610

5.  Growth promoting effects of human placental lactogen during early organogenesis: a link to insulin-like growth factors.

Authors:  A K Karabulut; R Layfield; M K Pratten
Journal:  J Anat       Date:  2001-06       Impact factor: 2.610

Review 6.  Modeling chick to assess diabetes pathogenesis and treatment.

Authors:  Savita P Datar; Ramesh R Bhonde
Journal:  Rev Diabet Stud       Date:  2011-08-10

7.  Maternal diabetes mellitus--early consequences for the offspring.

Authors:  Amanda Magaton; Frida Zaladek Gil; Dulce Elena Casarini; Maria de Fatima Cavanal; Guiomar Nascimento Gomes
Journal:  Pediatr Nephrol       Date:  2006-09-12       Impact factor: 3.714

Review 8.  Proinsulin in development: New roles for an ancient prohormone.

Authors:  C Hernández-Sánchez; A Mansilla; E J de la Rosa; F de Pablo
Journal:  Diabetologia       Date:  2006-04-05       Impact factor: 10.122

9.  Angiotensin II is a growth factor in the peri-implantation rat embryo.

Authors:  C Tebbs; M K Pratten; F Broughton Pipkin
Journal:  J Anat       Date:  1999-07       Impact factor: 2.610

10.  Functional roles of insulin and insulinlike growth factors in preimplantation mouse embryo development.

Authors:  L V Rao; M L Wikarczuk; S Heyner
Journal:  In Vitro Cell Dev Biol       Date:  1990-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.